Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulation
J. C. HOFFMANN, C. HERKLOTZ, H. ZEIDLER, B. BAYER, J. WESTERMANNVolume:
110
Year:
1997
Language:
english
Pages:
9
DOI:
10.1111/j.1365-2249.1997.488-ce1385.x
File:
PDF, 1.18 MB
english, 1997